Serum prolidase activity and oxidative status in patients with diabetic neuropathy

Neurological Sciences

Volumn 33, Issue 4, 2012, Pages 875-880

  Uzar, Ertugrul ^a   Tamam, Yusuf ^a   Evliyaoglu, Osman ^a   Tuzcu, Alpaslan ^a   Beyaz, Coskun ^a   Acar, Abdullah ^a   Aydn, Birsen ^a   Tasdemir, Nebahat ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diabetic neuropathy; Oxidative stress index; Prolidase; Total antioxidant status; Total oxidant status

Indexed keywords

PROLINE DIPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; PATHOGENESIS; SENSORY NERVE CONDUCTION; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDATIVE STATUS;

ADULT; AGED; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; DIABETIC NEUROPATHIES; DIPEPTIDASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; OXIDATION-REDUCTION; OXIDATIVE STRESS; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC;

EID: 84863990462     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0857-0     Document Type: Article

References (27)

1. Barbosa AP, Medina JL, Ramos EP, Barros HP (2001) Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population. Diabetes Metab 27:496-502 (Pubitemid 32852459)
2. Hoeldtke RD, Bryner KD, VanDyke K (2011) Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res 21:19-28
3. Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S (2008) Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 14:962-968 (Pubitemid 351753283)
4. Kamboj SS, Vasishta RK, Sandhir R (2010) N-acetylcysteine inhibits hyperglycemia induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem 112:77-91
5. dos Santos Sales IM, do Nascimento KG, Feitosa CM, Saldanha GB, Feng D, de Freitas RM (2011) Caffeic acid effects on oxidative stress in rat hippocampus after pilocarpine-induced seizures. Neurol Sci 32:375-380
6. Vincent AM, Kato K, McLean LL, Soules ME, Feldman EL (2009) Sensory neurons and Schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxid Redox Signal 11:425-438
7. Figueroa-Romero C, Sadidi M, Feldman EL (2008) Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 9:301-314
8. Yokoyama H, Uchida H, Kuroiwa H, Kasahara J, Araki T (2011) Role of glial cells in neurotoxin-induced animal models of Parkinson's disease. Neurol Sci 32:1-7
9. Cakmak A, Soker M, Koc A, Erel O (2009) Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major. J Pediatr Hematol Oncol 31:583-587
10. Aslan M, Sabuncu T, Kocyigit A, Celik H, Selek S (2007) Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 17:734-740 (Pubitemid 350088438)
11. Araki S, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T, Maegawa H (2010) Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 33:1805-1810
12. Hill R (2009) Extracellular matrix remodelling in human diabetic neuropathy. J Anat 214:219-225
13. Bradley JL, King RH, Muddle JR, Thomas PK (2000) The extracellular matrix of peripheral nerve in diabetic polyneuropathy. Acta Neuropathol 99:539-546 (Pubitemid 30201317)
14. Arkkila PE, Ronnemaa T, Koskinen PJ, Kantola IM, Seppanen E, Viikari JS (2001) Biochemical markers of type III and I collagen: association with retinopathy and neuropathy in type 1 diabetic subjects. Diabet Med 18:816-821 (Pubitemid 32953788)
15. Savas M, Yeni E, Verit A, Gulum M, Aksoy N, Ciftci H, Celik H, Altunkol A, Oncel H (2010) Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction. Clinics (Sao Paulo) 65:1311-1314
16. Expert Committee on the Diagnosis, Classification of diabetes mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26:5-20
17. Bril V, Perkins BA (2002) Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25:2048-2052 (Pubitemid 41071067)
18. American Diabetes Association (1998) Report and recommendations of the San Antonio Conference on diabetic neuropathy. Muscle Nerve 11:661-667
19. Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112-119 (Pubitemid 38077161)
20. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103-1111
21. Myara I, Charpentier C, Lemonnier A (1982) Optimal conditions for prolidase assay by proline colorimetric determination: application to imminodipeptiduria. Clin Chim Acta 125:193-205 (Pubitemid 12002380)
22. Chinard FP (1952) Photometric estimation of proline and ornithine. J Biol Chem 199:91-95
23. Chistiakov DA, Zotova EV, Savost'anov KV, Bursa TR, Galeev IV, Strokov IA, Nosikov VV (2006) The 262T[C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab 32:63-68 (Pubitemid 43872597)
24. Ozkul A, Ayhan M, Yenisey C, Akyol A, Guney E, Ergin FA (2010) The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain. Neuro Endocrinol Lett 31:261-264
25. Dordevic G, Duric S, Apostolskit S, Dordevic V, Zivkovic M (2008) Total antioxidant blood capacity in patients with type 2 diabetes mellitus and distal symmetrical polyneuropathy. Vojnosanit Pregl 65:663-669
26. Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, Aksoy N, Ocak AR, Erel O (2008) The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 19:319-325
27. Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES (2002) Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem 35:263-268 (Pubitemid 34804895)